Find the artificial intelligence based software for pathology that you are looking for. All products listed are available for the European market (CE-IVD marked).
The data presented in the pathology domain is under a publication embargo until May 2026 and should not be used for publication purposes until the embargo period has ended.
105 of 105 products
105/105
products
|
Sort by:
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Disease specific biomarkers
Paige Prostate Biomarker Panel detects foci of prostate carcinoma that are likely positive for mutations on digital images from prostate biopsies & resections. If morphological phenotypes consistent with the following mutations are detected, it will classify the sample as positive. Androgen Receptor (AR) amplification: AR Compound tumor suppressor genes alterations, includes alterations in Tumour protein p53 (TP53), Phosphatase and tensin homolog (PTEN), Retinoblastoma protein 1 (RB1).
Subspeciality: Gastrointestinal pathology
Modality: Histopathology
Source:
No key features available
Paige Colon Detect identifies foci suspicious for colon carcinoma and high-grade dysplasia (HGD).
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
Paige Breast Detect & Neoplasm highlights foci suspicious for cancer and pre-cancerous neoplasms. For use with digitized H&E stained breast biopsy & excision images. It is the responsibility of a qualified pathologist to employ appropriate procedures to assure the quality of the images obtained and use manual visualization and re-evaluate the product’s results before incorporating in the final diagnosis. Results of the device shall only be considered after a professional pathologist’s initial review of the entire WSI.
Subspeciality: Breast pathology
Modality: Histopathology
Source:
Subspeciality: Breast pathology
Modality: Histopathology
Source: Vendor
Breast cancer detection, HER2 classification
Aiforia® Breast Cancer HER2 detects invasive carcinoma and scores HER2 expression in accordance with CAP guidelines.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Vendor
Breast cancer detection, Quantification of PR-positive and negative tumor cells
Aiforia® Breast Cancer PR automatically detects invasive carcinoma and quantifies PR-positive and PR-negative cells in whole slide images (WSI) or selected tissue regions. The aim of the software is to enhance diagnostic clarity and improve workflow efficiency.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Vendor
Breast cancer detection, Quantification of ER-positive and negative tumor cells
Aiforia® Breast Cancer ER automatically detects invasive carcinoma and quantifies ER-positive and ER-negative tumor cells in whole slide images (WSI) or selected tissue areas, providing consistent and objective scoring to support breast cancer diagnostics.
Subspeciality: Pulmonary pathology
Modality: Histopathology
Source: Vendor
Lung cancer detection
Aiforia® Lung Cancer PD-L1 automatically detects invasive carcinoma and provides standardized, reproducible tumor proportion scoring (TPS). The software aims to support pathologists by reducing subjectivity and time demands in PD-L1 assessment, to improve diagnostic accuracy and efficiency.
Subspeciality: Uropathology
Modality: Histopathology
Source: Vendor
Detection of perineural invasion features
Aiforia® Prostate Cancer PNI detects subtle perineural invasion (PNI) features and identifies tumor involvement around nerves.
